Total number of shares and voting rights in Zealand at November 30, 2017
November 30, 2017 05:12 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 53 / 2017 ...
Financial calendar for Zealand Pharma in 2018
November 30, 2017 03:07 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 52/2017 ...
Zealand Pharma to attend three U.S. healthcare conferences in December
November 29, 2017 04:37 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press release - No. 12 / 2017Zealand...
Zealand increases its share capital as a consequence of exercise of employee warrants
November 20, 2017 08:52 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 51 / 2017 ...
Recruitment completed in trial to evaluate the optimal dosing frequency for Zealand's long-acting GLP-2 analog glepaglutide
November 14, 2017 02:36 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press Release- No. 11/2017 Recruitment...
Zealand Pharma: Interim report for the first nine months of 2017
November 08, 2017 09:00 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 50/2017 ...
Zealand Pharma will attend the Jefferies Healthcare Conference in London and the Bryan Garnier & Co Healthcare Conference in Paris, both in November
November 07, 2017 08:47 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press release - No. 10 / 2017Zealand...
Zealand reports royalty revenue for the third quarter of 2017
November 02, 2017 02:39 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 49/2017 ...
U.S. FDA grants orphan drug designation to glepaglutide for the treatment of short bowel syndrome
October 24, 2017 06:43 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No....
Zealand has initiated a clinical trial to evaluate the potential for less than once-daily dosing with its long-acting GLP-2 analog glepaglutide
October 12, 2017 07:04 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press release - No. 9/2017 Zealand has...